1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1. Drivers
4.1.1. Growing aging population
4.1.2. Rise in technology advancements and emerging economies
4.1.3. High preference of minimally invasive procedures
4.1.4. Rising patient awareness levels
4.2. Restraints
4.2.1. High maintenance and expensive treatment
4.2.2. Stringent regulatory approval procedures
4.3. Opportunities
4.3.1. Rapid growth in emerging countries
4.3.2. Increasing product launches
4.4. Challenges
4.4.1. The requirement of skilled healthcare professionals
4.4.2. Economic difficulties and government regulations
5. North America Cardiovascular Devices Market– By Type
5.1 Cardiac Rhythm Management (CRM)
5.1.1. Defibrillators
5.1.2. Pacemakers
5.2 Cardiac Monitoring Devices
5.2.1. Electrocardiogram (ECG)
5.2.2. Holter Monitor
5.2.3. Event Monitors
5.2.4. Implantable Loop Recorders
5.2.5. Cardiac output monitoring devices
5.2.6. Others
5.3 Cardiac Surgery Devices
5.3.1. On pump CABG perfusion circuit devices
5.3.2. Off-pump CABG devices
5.3.3. Endoscopic vessel harvesting devices
5.3.4. Anastomosis-assist devices
5.4 Interventional cardiology and peripheral vascular devices
5.4.1. Catheters
5.4.2. Angioplasty Balloons
5.4.3. Angioplasty Stents
5.4.4. Endovascular Aneurysm Repair (EVAR) Stent Grafts
5.5. Plaque Modification Devices
5.6. Flow Alteration Devices
5.7. Others
6. North America Cardiovascular Devices Market– By Procedure
6.1 Minimally Invasive Heart Surgery
6.2 Open heart surgery
6.3 Cardiac resynchronization therapy (CRT)
6.4 Angioplasty
6.4 Heart Valve Repair or Replacement
6.5 Others
7. North America Cardiovascular Devices Market– By Technology
7.1. Cardiopulmonary Bypass Product
7.2. Cardiac Assist Devices
7.3. Bioresorbable Stents
8. North America Cardiovascular Devices Market – By Application
8.1 Cardiac Arrhythmia
8.2 Myocardial Ischemia
8.3. Acute Myocardial Infarction
8.4 Congestive Heart Failure
9. North America Cardiovascular Devices Market – By End-Users
9.1. Hospitals
9.2. Clinics
9.3. Ambulatory Surgical Centres
10. North America Cardiovascular Devices Market– By Geography
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
11. North America Cardiovascular Devices Market– Company Profiles
11.1. Abbott Laboratories
11.2. Boston Scientific Corporation
11.3. Arrow International, Inc.
11.3. St. Jude Medical
11.4. Medtronic
11.5. GE Healthcare
11.6. SIEMENS Healthcare
11.7. LivaNova PLC
11.8. Johnson & Johnson
11.9. Edwards Lifesciences
11.10. Cardiac Science Corporation
11.11. AtriCure, Inc.
11.12. Cordis Corporation
11.13. Biosense Webster, Inc.
12. North America Cardiovascular Devices Market- Competitive Landscape
12.1. Market Share Analysis
12.2. Strategies Adopted by top companies
12.3. Mergers, Acquisitions, Collaborations & Agreements
13. Market Insights
13.1. Industry Experts Insights
13.2. Analysts Opinions
13.3. Investment Opportunities
14. Appendix
14.1. List of tables
14.2. List of figures
